|
| CXCR4 antagonists for treatment of breast cancer |
|
https://doi.org/10.18632/oncotarget.26090
Javier Cortés, Esther Holgado, and Jose Perez-Garcia
|
| 33442-33443 |
|
| Boosting chemokine receptor recycling: an elixir of life for chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.26099
Laura Patrussi, and Cosima T. Baldari
|
| 33444-33445 |
|
| RN765C a low affinity EGFR antibody drug conjugate with potent antitumor activity in preclinical solid tumor models |
|
https://doi.org/10.18632/oncotarget.26002
Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop, and Shu-Hui Liu
|
| 33446-33458 |
|
| TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.9663
Mohamad Elbaz, Dinesh Ahirwar, Zhang Xiaoli, Xinyu Zhou, Maryam Lustberg, Mohd W. Nasser, Konstantin Shilo, and Ramesh K. Ganju
|
| 33459-33470 |
|
| Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cellcycle arrest and apoptosis in glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.26033
Ramon Martinez-Olivera, Angeliki Datsi, Maren Stallkamp, Manfred Köller, Isabelle Kohtz, Bogdan Pintea, and Konstantinos Gousias
|
| 33471-33481 |
|
| Generation and characteristics of a novel “doublehit†high grade Bcell lymphoma cell line DHMy6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies |
|
https://doi.org/10.18632/oncotarget.26060
Hiroaki Kikuchi, Tomonori Higuchi, Yumiko Hashida, Ayuko Taniguchi, Mikio Kamioka, Takahiro Taguchi, Akihito Yokoyama, Ichiro Murakami, Mikiya Fujieda, and Masanori Daibata
|
| 33482-33499 |
|
| Comparative proteomic analysis of cat eye syndrome critical region protein 1 function in tumorassociated macrophages and immune response regulation of glial tumors |
|
https://doi.org/10.18632/oncotarget.26063
Changbin Zhu, Dana A.M. Mustafa, Merle M. Krebber, Ihsan Chrifi, Pieter J.M. Leenen, Dirk J. Duncker, Lennard Dekker, Theo M. Luider, Johan M. Kros, and Caroline Cheng
|
| 33500-33514 |
|
| SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Srcmediated premetastatic niche crosstalk |
|
https://doi.org/10.18632/oncotarget.26067
Masashi Muramatsu, Shin Akakura, Lingqiu Gao, Jennifer Peresie, Benjamin Balderman, and Irwin H. Gelman
|
| 33515-33527 |
|
| Clofarabinebased reduced intensity conditioning regimen with peripheral blood stem cell graft and posttransplant cyclophosphamide in adults with myeloid malignancies |
|
https://doi.org/10.18632/oncotarget.26083
Patrice Chevallier, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Anne Lok, Yannick Le Bris, Marie C. Béné, Steven Le Gouill, Philippe Moreau, and Thierry Guillaume
|
| 33528-33535 |
|
| Intestinal epithelial Notch1 protects from colorectal mucinous adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26086
David Dunkin, Alina C. Iuga, Sanda Mimouna, Carolyn L. Harris, Jean-Vianney Haure-Mirande, Dominique Bozec, Garabet Yeretssian, and Stephanie Dahan
|
| 33536-33548 |
|
| The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma |
|
https://doi.org/10.18632/oncotarget.26088
Hisham F. Bahmad, Tarek H. Mouhieddine, Reda M. Chalhoub, Sahar Assi, Tarek Araji, Farah Chamaa, Muhieddine M. Itani, Amaly Nokkari, Firas Kobeissy, Georges Daoud, and Wassim Abou-Kheir
|
| 33549-33561 |
|
| Elucidating the novel BRCA1 function as a nongenomic metabolic restraint in ERpositive breast cancer cell lines |
|
https://doi.org/10.18632/oncotarget.26093
Moses Koobotse, Jeff Holly, and Claire Perks
|
| 33562-33576 |
|
| MiR29b15p is altered in BRCA1 mutant tumours and is a biomarker in basallike breast cancer |
|
https://doi.org/10.18632/oncotarget.26094
Michael J.G. Milevskiy, Gurveen K. Sandhu, Anna Wronski, Darren Korbie, Brooke L. Brewster, Annette Shewan, Stacey L. Edwards, Juliet D. French, and Melissa A. Brown
|
| 33577-33588 |
|
| Adaptation to chronic exposure to sepantronium bromide YM155 a prototypical survivin suppressant is due to persistent DNA damageresponse in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.26096
Tasaduq H. Wani, Sreeraj Surendran, Vishnu S. Mishra, Jaya Chaturvedi, Goutam Chowdhury, and Anindita Chakrabarty
|
| 33589-33600 |
|
| Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study |
|
https://doi.org/10.18632/oncotarget.26035
Md. Jakaria, Md. Ezazul Haque, Joonsoo Kim, Duk-Yeon Cho, In-Su Kim, and Dong-Kug Choi
|
| 33601-33620 |
